CD2-associated protein (CD2AP) enhances casitas B lineage lymphoma-3/c (Cbl-3/c)-mediated Ret isoform-specific ubiquitination and degradation via its amino-terminal Src homology 3 domains.

Gina N Calco, Olivia R Stephens, Laura M Donahue, Cynthia C Tsui, Brian A Pierchala
Author Information
  1. Gina N Calco: From the Department of Biologic and Materials Sciences, The University of Michigan School of Dentistry, Ann Arbor, Michigan 48109 and.

Abstract

Ret is the receptor tyrosine kinase for the glial cell line-derived neurotrophic factor (GDNF) family of neuronal growth factors. Upon activation by GDNF, Ret is rapidly polyubiquitinated and degraded. This degradation process is isoform-selective, with the longer Ret51 isoform exhibiting different degradation kinetics than the shorter isoform, Ret9. In sympathetic neurons, Ret degradation is induced, at least in part, by a complex consisting of the adaptor protein CD2AP and the E3-ligase Cbl-3/c. Knockdown of Cbl-3/c using siRNA reduced the GDNF-induced ubiquitination and degradation of Ret51 in neurons and podocytes, suggesting that Cbl-3/c was a predominant E3 ligase for Ret. Coexpression of CD2AP with Cbl-3/c augmented the ubiquitination of Ret51 as compared with the expression of Cbl-3/c alone. Ret51 ubiquitination by the CD2AP·Cbl-3/c complex required a functional ring finger and TKB domain in Cbl-3/c. The SH3 domains of CD2AP were sufficient to drive the Cbl-3/c-dependent ubiquitination of Ret51, whereas the carboxyl-terminal coiled-coil domain of CD2AP was dispensable. Interestingly, activated Ret induced the degradation of CD2AP, but not Cbl-3/c, suggesting a potential inhibitory feedback mechanism. There were only two major ubiquitination sites in Ret51, Lys(1060) and Lys(1107), and the combined mutation of these lysines almost completely eliminated both the ubiquitination and degradation of Ret51. Ret9 was not ubiquitinated by the CD2AP·Cbl-3/c complex, suggesting that Ret9 was down-regulated by a fundamentally different mechanism. Taken together, these results suggest that only the SH3 domains of CD2AP were necessary to enhance the E3 ligase activity of Cbl-3/c toward Ret51.

Keywords

References

  1. Kidney Int. 2010 Nov;78(9):868-82 [PMID: 20664558]
  2. Immunity. 2004 Jul;21(1):7-17 [PMID: 15345216]
  3. J Biol Chem. 2005 Apr 8;280(14):13442-9 [PMID: 15677445]
  4. Science. 1999 Oct 8;286(5438):309-12 [PMID: 10514377]
  5. Traffic. 2003 Feb;4(2):97-112 [PMID: 12559036]
  6. Gene. 1999 Oct 18;239(1):145-54 [PMID: 10571044]
  7. Nat Rev Neurosci. 2002 May;3(5):383-94 [PMID: 11988777]
  8. Mol Cell. 1999 Dec;4(6):1029-40 [PMID: 10635327]
  9. Oncogene. 1999 Jun 3;18(22):3365-75 [PMID: 10362357]
  10. Nature. 2002 Mar 14;416(6877):183-7 [PMID: 11894095]
  11. Cell. 2012 Feb 3;148(3):568-82 [PMID: 22304922]
  12. J Biol Chem. 2003 Oct 10;278(41):39735-46 [PMID: 12874286]
  13. J Biol Chem. 2010 Jul 30;285(31):23687-98 [PMID: 20525694]
  14. Nat Genet. 2011 May;43(5):436-41 [PMID: 21460841]
  15. Nat Rev Mol Cell Biol. 2001 Mar;2(3):195-201 [PMID: 11265249]
  16. Trends Pharmacol Sci. 2007 Feb;28(2):68-74 [PMID: 17218019]
  17. J Biol Chem. 2004 Apr 30;279(18):18262-9 [PMID: 14766744]
  18. J Biol Chem. 2001 Feb 16;276(7):4957-63 [PMID: 11067845]
  19. Curr Opin Cell Biol. 2003 Apr;15(2):184-90 [PMID: 12648674]
  20. Mol Cell. 2001 Feb;7(2):355-65 [PMID: 11239464]
  21. J Neurosci. 1999 Oct 1;19(19):8207-18 [PMID: 10493722]
  22. Nat Genet. 2011 May;43(5):429-35 [PMID: 21460840]
  23. Curr Opin Neurobiol. 2000 Feb;10(1):103-10 [PMID: 10679429]
  24. Mol Biol Cell. 2012 Oct;23(19):3838-50 [PMID: 22875993]
  25. Nature. 2009 Aug 13;460(7257):904-8 [PMID: 19620960]
  26. Clin Cancer Res. 2009 Dec 1;15(23):7119-23 [PMID: 19934298]
  27. Curr Biol. 2000 Jan 27;10(2):R84-7 [PMID: 10662664]
  28. Nature. 2002 Mar 14;416(6877):187-90 [PMID: 11894096]
  29. Oncogene. 2004 Mar 4;23(9):1645-55 [PMID: 14661060]
  30. Annu Rev Cell Dev Biol. 1998;14:19-57 [PMID: 9891777]
  31. J Neurosci. 2001 Mar 1;21(5):1464-72 [PMID: 11222636]
  32. J Am Soc Nephrol. 2006 Jun;17(6):1543-52 [PMID: 16672314]
  33. J Cell Physiol. 2006 Oct;209(1):21-43 [PMID: 16741904]
  34. J Biol Chem. 2002 Oct 18;277(42):39666-72 [PMID: 12177062]
  35. J Biol Chem. 2007 Mar 9;282(10):7457-64 [PMID: 17213204]
  36. J Neurosci. 2006 Mar 8;26(10):2777-87 [PMID: 16525057]
  37. J Neurosci. 2008 Aug 27;28(35):8789-800 [PMID: 18753381]
  38. J Neurosci. 2010 Apr 14;30(15):5149-58 [PMID: 20392937]
  39. FASEB J. 2004 May;18(7):929-31 [PMID: 15001553]
  40. J Biol Chem. 2002 Sep 13;277(37):34618-25 [PMID: 12091387]

Grants

  1. K08 DK084210/NIDDK NIH HHS
  2. R01 NS058510/NINDS NIH HHS

MeSH Term

Adaptor Proteins, Signal Transducing
Animals
Cytoskeletal Proteins
Gene Knockdown Techniques
Gene Silencing
Lysine
Mice
Mutation
NIH 3T3 Cells
Phosphorylation
Podocytes
Protein Isoforms
Proto-Oncogene Proteins c-cbl
Proto-Oncogene Proteins c-ret
Signal Transduction
Ubiquitin
Ubiquitination
src Homology Domains

Chemicals

Adaptor Proteins, Signal Transducing
CD2-associated protein
Cytoskeletal Proteins
Protein Isoforms
Ubiquitin
Proto-Oncogene Proteins c-cbl
Proto-Oncogene Proteins c-ret
Ret protein, mouse
Cblc protein, mouse
Lysine

Word Cloud

Created with Highcharts 10.0.0Cbl-3/cRet51degradationCD2APubiquitinationRetRet9complexsuggestingdomainsGDNFisoformdifferentneuronsinducedproteinE3ligaseCD2AP·Cbl-3/cdomainSH3mechanismLysreceptortyrosinekinaseglialcellline-derivedneurotrophicfactorfamilyneuronalgrowthfactorsUponactivationrapidlypolyubiquitinateddegradedprocessisoform-selectivelongerexhibitingkineticsshortersympatheticleastpartconsistingadaptorE3-ligaseKnockdownusingsiRNAreducedGDNF-inducedpodocytespredominantCoexpressionaugmentedcomparedexpressionalonerequiredfunctionalringfingerTKBsufficientdriveCbl-3/c-dependentwhereascarboxyl-terminalcoiled-coildispensableInterestinglyactivatedpotentialinhibitoryfeedbacktwomajorsites10601107combinedmutationlysinesalmostcompletelyeliminatedubiquitinateddown-regulatedfundamentallyTakentogetherresultssuggestnecessaryenhanceactivitytowardCD2-associatedenhancescasitasBlineagelymphoma-3/c-mediatedisoform-specificviaamino-terminalSrchomology3NeurodevelopmentNeurotrophicFactorProteinDegradationReceptorTyrosineKinaseUbiquitination

Similar Articles

Cited By